1. Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group. Issue 6 (12th May 2019) Authors: Rueda, Antonio; Calvo, Virginia; Casanova, María; Rodriguez-Abreu, Delvys; Aguiar, David; Llanos, Marta; Alvarez, Ruth; Martinez-Banaclocha, Natividad; Alfaro, Jesús; Quero, Cristina; Blasco, Ana; de la Cruz Merino, Luis; Herrero, Joaquín; García-Arroyo, Francisco R; Provencio, Mariano Journal: Leukemia & lymphoma Issue: Volume 60:Issue 6(2019) Page Start: 1576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term follow‐up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group. Issue 4 (2nd February 2021) Authors: Núñez‐García, Beatriz; Rodríguez‐Pertierra, Marta; Sequero, Silvia; Carvajal, Laura G.; Ruano‐Ravina, Alberto; Aguiar, David; Gumá, Josep; Blanco, Cristina Q.; García Arroyo, Francisco R.; Garitaonaindia, Yago; Provencio, Zaida; Calvo, Virginia; González‐San Segundo, Carmen; Provencio, Mariano Journal: Hematological oncology Issue: Volume 39:Issue 4(2021) Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic value of event‐free survival at 12 and 24 months and long‐term mortality for non‐Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group. Issue 19 (13th June 2017) Authors: Provencio, Mariano; Royuela, Ana; Torrente, María; Pollán, Marina; Gómez‐Codina, José; Sabín, Pilar; Llanos, Marta; Gumá, Josep; Quero, Cristina; Blasco, Ana; Aguiar, David; García‐Arroyo, Francisco Ramón; Lavernia, Javier; Martínez, Natividad; Morales, Manuel; Saenz‐Cusi, Álvaro; Rodríguez, Delv... Journal: Cancer Issue: Volume 123:Issue 19(2017) Page Start: 3709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation. (August 2020) Authors: Barquín, Miguel; Calvo, Virginia; García-García, Francisco; Nuñez, Beatriz; Sánchez-Herrero, Estela; Serna-Blasco, Roberto; Auglytė, Milda; Carcereny, Enric; Rodriguez-Abreu, Delvys; López Castro, Rafael; Guirado, María; Camps, Carlos; Bosch-Barrera, Joaquín; Massuti, Bartomeu; Ortega, Ana Laura;... Journal: Cancer epidemiology Issue: Volume 67(2020:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗